China · Delayed Price · Currency is CNY Zhejiang Medicine Statistics
Total Valuation
SHA:600216 has a market cap or net worth of CNY 10.56 billion. The enterprise value is 8.11 billion.
| Market Cap | 10.56B |
| Enterprise Value | 8.11B |
Important Dates
The last earnings date was Wednesday, October 28, 2026.
| Earnings Date | Oct 28, 2026 |
| Ex-Dividend Date | Jul 9, 2026 |
Share Statistics
SHA:600216 has 947.91 million shares outstanding. The number of shares has decreased by -0.23% in one year.
| Current Share Class | 947.91M |
| Shares Outstanding | 947.91M |
| Shares Change (YoY) | -0.23% |
| Shares Change (QoQ) | +0.66% |
| Owned by Insiders (%) | 0.32% |
| Owned by Institutions (%) | 5.35% |
| Float | 569.33M |
Valuation Ratios
The trailing PE ratio is 16.92 and the forward PE ratio is 11.14.
| PE Ratio | 16.92 |
| Forward PE | 11.14 |
| PS Ratio | 1.25 |
| PB Ratio | 0.89 |
| P/TBV Ratio | 0.97 |
| P/FCF Ratio | 22.98 |
| P/OCF Ratio | 10.65 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.12, with an EV/FCF ratio of 17.65.
| EV / Earnings | 12.81 |
| EV / Sales | 0.96 |
| EV / EBITDA | 6.12 |
| EV / EBIT | 13.01 |
| EV / FCF | 17.65 |
Financial Position
The company has a current ratio of 3.59, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.59 |
| Quick Ratio | 2.49 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.70 |
| Debt / FCF | 2.03 |
| Interest Coverage | 26.99 |
Financial Efficiency
Return on equity (ROE) is 3.85% and return on invested capital (ROIC) is 5.29%.
| Return on Equity (ROE) | 3.85% |
| Return on Assets (ROA) | 2.70% |
| Return on Invested Capital (ROIC) | 5.29% |
| Return on Capital Employed (ROCE) | 4.97% |
| Weighted Average Cost of Capital (WACC) | 6.21% |
| Revenue Per Employee | 1.56M |
| Profits Per Employee | 116,861 |
| Employee Count | 5,417 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 2.81 |
Taxes
In the past 12 months, SHA:600216 has paid 127.37 million in taxes.
| Income Tax | 127.37M |
| Effective Tax Rate | 22.29% |
Stock Price Statistics
The stock price has decreased by -23.07% in the last 52 weeks. The beta is 0.42, so SHA:600216's price volatility has been lower than the market average.
| Beta (5Y) | 0.42 |
| 52-Week Price Change | -23.07% |
| 50-Day Moving Average | 12.26 |
| 200-Day Moving Average | 13.58 |
| Relative Strength Index (RSI) | 38.73 |
| Average Volume (20 Days) | 13,713,223 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600216 had revenue of CNY 8.43 billion and earned 633.03 million in profits. Earnings per share was 0.66.
| Revenue | 8.43B |
| Gross Profit | 2.59B |
| Operating Income | 623.69M |
| Pretax Income | 571.44M |
| Net Income | 633.03M |
| EBITDA | 1.32B |
| EBIT | 623.69M |
| Earnings Per Share (EPS) | 0.66 |
Balance Sheet
The company has 3.77 billion in cash and 931.41 million in debt, with a net cash position of 2.84 billion or 2.99 per share.
| Cash & Cash Equivalents | 3.77B |
| Total Debt | 931.41M |
| Net Cash | 2.84B |
| Net Cash Per Share | 2.99 |
| Equity (Book Value) | 11.88B |
| Book Value Per Share | 11.84 |
| Working Capital | 5.70B |
Cash Flow
In the last 12 months, operating cash flow was 991.62 million and capital expenditures -532.04 million, giving a free cash flow of 459.58 million.
| Operating Cash Flow | 991.62M |
| Capital Expenditures | -532.04M |
| Depreciation & Amortization | 700.78M |
| Net Borrowing | 50.74M |
| Free Cash Flow | 459.58M |
| FCF Per Share | 0.48 |
Margins
Gross margin is 30.69%, with operating and profit margins of 7.40% and 7.51%.
| Gross Margin | 30.69% |
| Operating Margin | 7.40% |
| Pretax Margin | 6.78% |
| Profit Margin | 7.51% |
| EBITDA Margin | 15.71% |
| EBIT Margin | 7.40% |
| FCF Margin | 5.45% |
Dividends & Yields
This stock pays an annual dividend of 0.28, which amounts to a dividend yield of 2.51%.
| Dividend Per Share | 0.28 |
| Dividend Yield | 2.51% |
| Dividend Growth (YoY) | -24.32% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 45.98% |
| FCF Payout Ratio | 57.75% |
| Buyback Yield | 0.23% |
| Shareholder Yield | 2.75% |
| Earnings Yield | 5.91% |
| FCF Yield | 4.35% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
| Graham Formula Value | |
| Graham Formula Upside |
Analyst Forecast
The average price target for SHA:600216 is 15.25, which is 36.89% higher than the current price. The consensus rating is "Buy".
| Price Target | 15.25 |
| Price Target Difference | 36.89% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 3.39% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
The last stock split was on October 9, 2013. It was a forward split with a ratio of 1.8.
| Last Split Date | Oct 9, 2013 |
| Split Type | Forward |
| Split Ratio | 1.8 |
Scores
SHA:600216 has an Altman Z-Score of 4.77 and a Piotroski F-Score of 5.
| Altman Z-Score | 4.77 |
| Piotroski F-Score | 5 |